Clinical Trial Update: Study of SHP620 (Maribavir) in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial update of SHP620 (Maribavir) in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• SHP620 (Maribavir) (maribavir)

Snippet

Sponsor: Shire | Conditions: Cytomegalovirus (CMV) | Phase 1 | Status: COMPLETED | Results posted: 2019-01-16